Comparison

Molecules

1437732 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Elacestrant Chemicals Other Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD). DCC-DC70104-100mg

DCChemicals
100 mg Login
Compare
Elacestrant Chemicals Other Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD). DCC-DC70104-250mg

DCChemicals
250 mg Login
Compare
Elacestrant Chemicals Other Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD). DCC-DC70104-1g

DCChemicals
1 g Login
Compare
AC1-­IN-­38 Chemicals Other other DCC-DC70169-100mg

DCChemicals
100 mg Login
Compare
AC1-­IN-­38 Chemicals Other other DCC-DC70169-250mg

DCChemicals
250 mg Login
Compare
AC1-­IN-­38 Chemicals Other other DCC-DC70169-1g

DCChemicals
1 g Login
Compare
FGIN-­1-­27 Chemicals Other FGIN-1-27 is an anxiolytic compound that acts as a selective agonist at the peripheral benzodiazepine receptor (TSPO).FGIN-1-27 inhibited Th17 cell differentiation, significantly downregulated the expression of RORγt target genes, notably Il17a, Il17f, Il23r, Ltb4r1, Ccr6.FGIN-1-27 protected mice against EAE, induced amino acid starvation response (AAR), FGIN-1-27 produced anti-anxiety and anti-panic effects in non-mammalian models. DCC-DC70409-100mg

DCChemicals
100 mg Login
Compare
FGIN-­1-­27 Chemicals Other FGIN-1-27 is an anxiolytic compound that acts as a selective agonist at the peripheral benzodiazepine receptor (TSPO).FGIN-1-27 inhibited Th17 cell differentiation, significantly downregulated the expression of RORγt target genes, notably Il17a, Il17f, Il23r, Ltb4r1, Ccr6.FGIN-1-27 protected mice against EAE, induced amino acid starvation response (AAR), FGIN-1-27 produced anti-anxiety and anti-panic effects in non-mammalian models. DCC-DC70409-250mg

DCChemicals
250 mg Login
Compare
Bemcentinib(R428,BGB324) Inhibitors Other DCC-DC7258-250mg

DCChemicals
250 mg Login
Compare
Bemcentinib(R428,BGB324) Inhibitors Other DCC-DC7258-1g

DCChemicals
1 g Login
Compare
Resminostat hydrochloride (4SC-­201) Inhibitors Other DCC-DC7261-100mg

DCChemicals
100 mg Login
Compare
Resminostat hydrochloride (4SC-­201) Inhibitors Other DCC-DC7261-250mg

DCChemicals
250 mg Login
Compare
Resminostat hydrochloride (4SC-­201) Inhibitors Other DCC-DC7261-1g

DCChemicals
1 g Login
Compare
LCS3 Chemicals Other LCS3 inhibits glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) (IC50=3.3 µM and 3.8 µM, respectively) synergistically. LCS3 shows anti-tumor activity, and induces apoptosis. LCS3 can be used in lung adenocarcinoma (LUAD) research. DCC-DC71723-100mg

DCChemicals
100 mg Login
Compare
LCS3 Chemicals Other LCS3 inhibits glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) (IC50=3.3 µM and 3.8 µM, respectively) synergistically. LCS3 shows anti-tumor activity, and induces apoptosis. LCS3 can be used in lung adenocarcinoma (LUAD) research. DCC-DC71723-250mg

DCChemicals
250 mg Login
Compare
LCS3 Chemicals Other LCS3 inhibits glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) (IC50=3.3 µM and 3.8 µM, respectively) synergistically. LCS3 shows anti-tumor activity, and induces apoptosis. LCS3 can be used in lung adenocarcinoma (LUAD) research. DCC-DC71723-1g

DCChemicals
1 g Login
Compare
LDCA Chemicals Other LDCA is a dual-hit metabolic modulator and inhibits LDH-A enzyme activity to stimulate apoptosis in the malignant population. LDCA can be used for the research of oncogenic progression. DCC-DC71724-100mg

DCChemicals
100 mg Login
Compare
LDCA Chemicals Other LDCA is a dual-hit metabolic modulator and inhibits LDH-A enzyme activity to stimulate apoptosis in the malignant population. LDCA can be used for the research of oncogenic progression. DCC-DC71724-250mg

DCChemicals
250 mg Login
Compare
LDCA Chemicals Other LDCA is a dual-hit metabolic modulator and inhibits LDH-A enzyme activity to stimulate apoptosis in the malignant population. LDCA can be used for the research of oncogenic progression. DCC-DC71724-1g

DCChemicals
1 g Login
Compare
GLN-­1062 Chemicals Other GLN-1062 (Memogain) is an inactive pro-drug of galantamine, the latter being a plant alkaloid approved for the treatment of mild to moderate Alzheimer's disease. DCC-DC71898-100mg

DCChemicals
100 mg Login
Compare
GLN-­1062 Chemicals Other GLN-1062 (Memogain) is an inactive pro-drug of galantamine, the latter being a plant alkaloid approved for the treatment of mild to moderate Alzheimer's disease. DCC-DC71898-250mg

DCChemicals
250 mg Login
Compare
GLN-­1062 Chemicals Other GLN-1062 (Memogain) is an inactive pro-drug of galantamine, the latter being a plant alkaloid approved for the treatment of mild to moderate Alzheimer's disease. DCC-DC71898-1g

DCChemicals
1 g Login
Compare
WAY-­296817 Chemicals Other WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention. DCC-DC71902-100mg

DCChemicals
100 mg Login
Compare
WAY-­296817 Chemicals Other WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention. DCC-DC71902-250mg

DCChemicals
250 mg Login
Compare
WAY-­296817 Chemicals Other WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention. DCC-DC71902-1g

DCChemicals
1 g Login
Compare
Name Price
Elacestrant Login
Type Chemicals
Clone
Specific against Other
Appl. Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD).
Host
Item no.
Amount 100 mg
Available
Elacestrant Login
Type Chemicals
Clone
Specific against Other
Appl. Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD).
Host
Item no.
Amount 250 mg
Available
Elacestrant Login
Type Chemicals
Clone
Specific against Other
Appl. Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD).
Host
Item no.
Amount 1 g
Available
AC1-­IN-­38 Login
Type Chemicals
Clone
Specific against Other
Appl. other
Host
Item no.
Amount 100 mg
Available
AC1-­IN-­38 Login
Type Chemicals
Clone
Specific against Other
Appl. other
Host
Item no.
Amount 250 mg
Available
AC1-­IN-­38 Login
Type Chemicals
Clone
Specific against Other
Appl. other
Host
Item no.
Amount 1 g
Available
FGIN-­1-­27 Login
Type Chemicals
Clone
Specific against Other
Appl. FGIN-1-27 is an anxiolytic compound that acts as a selective agonist at the peripheral benzodiazepine receptor (TSPO).FGIN-1-27 inhibited Th17 cell differentiation, significantly downregulated the expression of RORγt target genes, notably Il17a, Il17f, Il23r, Ltb4r1, Ccr6.FGIN-1-27 protected mice against EAE, induced amino acid starvation response (AAR), FGIN-1-27 produced anti-anxiety and anti-panic effects in non-mammalian models.
Host
Item no.
Amount 100 mg
Available
FGIN-­1-­27 Login
Type Chemicals
Clone
Specific against Other
Appl. FGIN-1-27 is an anxiolytic compound that acts as a selective agonist at the peripheral benzodiazepine receptor (TSPO).FGIN-1-27 inhibited Th17 cell differentiation, significantly downregulated the expression of RORγt target genes, notably Il17a, Il17f, Il23r, Ltb4r1, Ccr6.FGIN-1-27 protected mice against EAE, induced amino acid starvation response (AAR), FGIN-1-27 produced anti-anxiety and anti-panic effects in non-mammalian models.
Host
Item no.
Amount 250 mg
Available
Bemcentinib(R428,BGB324) Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 250 mg
Available
Bemcentinib(R428,BGB324) Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 g
Available
Resminostat hydrochloride (4SC-­201) Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Resminostat hydrochloride (4SC-­201) Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 250 mg
Available
Resminostat hydrochloride (4SC-­201) Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 g
Available
LCS3 Login
Type Chemicals
Clone
Specific against Other
Appl. LCS3 inhibits glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) (IC50=3.3 µM and 3.8 µM, respectively) synergistically. LCS3 shows anti-tumor activity, and induces apoptosis. LCS3 can be used in lung adenocarcinoma (LUAD) research.
Host
Item no.
Amount 100 mg
Available
LCS3 Login
Type Chemicals
Clone
Specific against Other
Appl. LCS3 inhibits glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) (IC50=3.3 µM and 3.8 µM, respectively) synergistically. LCS3 shows anti-tumor activity, and induces apoptosis. LCS3 can be used in lung adenocarcinoma (LUAD) research.
Host
Item no.
Amount 250 mg
Available
LCS3 Login
Type Chemicals
Clone
Specific against Other
Appl. LCS3 inhibits glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) (IC50=3.3 µM and 3.8 µM, respectively) synergistically. LCS3 shows anti-tumor activity, and induces apoptosis. LCS3 can be used in lung adenocarcinoma (LUAD) research.
Host
Item no.
Amount 1 g
Available
LDCA Login
Type Chemicals
Clone
Specific against Other
Appl. LDCA is a dual-hit metabolic modulator and inhibits LDH-A enzyme activity to stimulate apoptosis in the malignant population. LDCA can be used for the research of oncogenic progression.
Host
Item no.
Amount 100 mg
Available
LDCA Login
Type Chemicals
Clone
Specific against Other
Appl. LDCA is a dual-hit metabolic modulator and inhibits LDH-A enzyme activity to stimulate apoptosis in the malignant population. LDCA can be used for the research of oncogenic progression.
Host
Item no.
Amount 250 mg
Available
LDCA Login
Type Chemicals
Clone
Specific against Other
Appl. LDCA is a dual-hit metabolic modulator and inhibits LDH-A enzyme activity to stimulate apoptosis in the malignant population. LDCA can be used for the research of oncogenic progression.
Host
Item no.
Amount 1 g
Available
GLN-­1062 Login
Type Chemicals
Clone
Specific against Other
Appl. GLN-1062 (Memogain) is an inactive pro-drug of galantamine, the latter being a plant alkaloid approved for the treatment of mild to moderate Alzheimer's disease.
Host
Item no.
Amount 100 mg
Available
GLN-­1062 Login
Type Chemicals
Clone
Specific against Other
Appl. GLN-1062 (Memogain) is an inactive pro-drug of galantamine, the latter being a plant alkaloid approved for the treatment of mild to moderate Alzheimer's disease.
Host
Item no.
Amount 250 mg
Available
GLN-­1062 Login
Type Chemicals
Clone
Specific against Other
Appl. GLN-1062 (Memogain) is an inactive pro-drug of galantamine, the latter being a plant alkaloid approved for the treatment of mild to moderate Alzheimer's disease.
Host
Item no.
Amount 1 g
Available
WAY-­296817 Login
Type Chemicals
Clone
Specific against Other
Appl. WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention.
Host
Item no.
Amount 100 mg
Available
WAY-­296817 Login
Type Chemicals
Clone
Specific against Other
Appl. WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention.
Host
Item no.
Amount 250 mg
Available
WAY-­296817 Login
Type Chemicals
Clone
Specific against Other
Appl. WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention.
Host
Item no.
Amount 1 g
Available

1437732 Item(s)

per page